Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Results of collagen cross-linking with riboflavin in paediatric patients with progressive keratoconus
Poster Details
First Author: B.Ratna INDIA
Co Author(s): R. Bakshi
Abstract Details
Purpose:
To assess the safety and efficacy of Corneal Collagen Cross linking with Riboflavin (CXL) using ultraviolet-A light in Children of 9-16 years of age with progressive keratoconus.
Setting:
Centre For Sight
Methods:
It was a retrospective case series of 25 eyes of 15 children with progressive keratoconus aged between 9-16 years. Mean follow up was 24.57 months (range 1 to 3 years). 6 out of 15 (40%) children had Vernal keratoconjunctivitis (VKC) associated keratoconus.
Results:
We had gratifying results in most of our patients. Mean pre-operative keratometry was 51.96 + 5.75 D, whereas which reduced to 48.73 + 3.83 D. Improvement in BCVA by one line or more was noted in all (100%) eyes at the last follow up. Mean pre-op aberration coefficient was 2.6+/-0.96 which reduced to 2.42+/-0.92 post operatively. There were no complications noted in our series except for mild haze and minimal scarring post-op which had no impact on BCVA
Conclusions:
Our study concluded that Collagen Cross Linking with Riboflavin is a safe and effective procedure in children with progressive keratoconus. FINANCIAL INTEREST: NONE